Oramed Pharmaceuticals Inc. (ORMP) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Oramed Pharmaceuticals In...

    NASDAQ: ORMP · Real-Time Price · USD
    2.44
    -0.07 (-2.93%)
    At close: Oct 03, 2025, 3:59 PM
    2.48
    1.64%
    After-hours: Oct 03, 2025, 07:11 PM EDT

    Oramed Pharmaceuticals Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Aug 31, 2021
    Cash & Equivalents
    		 54.42M 9.05M 40.46M 77.25M
    Short-Term Investments
    		 87.51M 152.99M 115.26M 16.89M
    Long-Term Investments
    		 10.91M 56.37M 2.7M 6.69M
    Other Long-Term Assets
    		 34K 34K 24K 25.04M
    Receivables
    		 n/a n/a n/a n/a
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 1.29M 537K 1.39M 1.2M
    Total Current Assets
    		 143.22M 162.58M 157.11M 95.34M
    Property-Plant & Equipment
    		 1.11M 1.57M 1.81M 932K
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 12.06M 57.97M 4.53M 32.66M
    Total Assets
    		 155.28M 220.55M 161.64M 128M
    Account Payables
    		 789K 551K 2.17M 2.61M
    Deferred Revenue
    		 n/a n/a 1.34M 2.7M
    Short-Term Debt
    		 n/a 51.01M 247K 130K
    Other Current Liabilities
    		 n/a 325K 1.98M 1.24M
    Total Current Liabilities
    		 5.68M 53.21M 5.75M 6.68M
    Long-Term Debt
    		 n/a n/a 647K 403K
    Other Long-Term Liabilities
    		 90K 102K 82K 145K
    Total Long-Term Liabilities
    		 4.25M 4.44M 4.74M 4.8M
    Total Liabilities
    		 9.93M 57.66M 10.49M 11.48M
    Total Debt
    		 372K 51.62M 894K 533K
    Book Value
    		 145.35M 162.89M 151.16M 116.52M
    Book Value Per Share
    		 3.56 4.04 3.88 4.09
    Common Stock
    		 480K 485K 476K 424K
    Retained Earnings
    		 -176.62M -157.56M -163.08M -114.85M
    Comprehensive Income
    		 n/a n/a n/a n/a
    Shareholders Equity
    		 146.26M 163.82M 151.81M 115.77M
    Total Investments
    		 98.42M 207.92M 117.96M 23.59M

    Add to Watchlist